Mr Shaw works as a Consultant in Urology and robotic surgery at University College London Hospitals (UCLH) and honorary consultant at Barts Health NHS Trust.
Mr Shaw qualified in medicine at St Bartholomew’s Medical College in 1999. His focus on prostate cancer started with an MD research degree at St Bartholomew’s Hospital in 2005. Thereafter he trained as a urologist in North London where he earned Fellowship of the Royal College of Surgeons. He is listed on the specialist register of the GMC for Urology (GMC number: 4626222).
In order to further develop my interest in prostate cancer Mr Shaw took up a four year Lectureship at The University of Cambridge working in a world class research team and generating important findings from his research.
In Cambridge he began to develop his interest in robotic surgery which was consolidated through the prestigious Royal College of Surgeons of England Fellowship program which he completed in 2015.
He now performs 150 robotic prostatectomies per year, amongst the highest rate for UK urologists. Mr Shaw strives to evaluate and incorporate the best technical modifications to attain excellent results for his patients.
Mr Shaw is an honorary senior lecturer at University College London and Queen Mary University of London (QMUL). He leads on the PROVENT to evaluate the effects of aspirin and vitamin D on prostate cancer progression for men being treated with active surveillance and the NeuroSAFE PROOF study to evaluate the cost effectiveness of the NeuroSAFE procedure.